Concomitant Use of an Immunomodulator With Ustekinumab as Induction Therapy for Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Concomitant Use of an Immunomodulator With Ustekinumab as an Induction Therapy for Crohn's Disease: A Systematic Review and Meta-Analysis
J. Gastroenterol. Hepatol. 2021 Jan 15;[EPub Ahead of Print], T Yoshihara, S Shinzaki, T Amano, H Iijima, T Takehara, N Inoue, M Uchino, M Esaki, T Kobayashi, M Saruta, K Sugimoto, S Nakamura, K Hata, F Hirai, S Hiraoka, T Fujii, M Matsuura, K Matsuoka, K Watanabe, H Nakase, M WatanabeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.